Stock report · Delisted · Nasdaq
Qualigen Therapeutics Inc (QLGN)
2.33USD Delisted Final close · Jan 20, 2026
QLGN no longer trades. Qualigen Therapeutics was delisted from the Nasdaq in January 2026.
All prices on this page are historical. The last trade was on January 20, 2026, at $2.33.
QLGN stock price history
Final trading statistics
- Final close
- $2.33
- Final trading day
- Jan 20, 2026
- Market cap at delisting
- $4.74M
- Shares outstanding
- 2.03M
- Final 52-week range
- $1.61 – $8.81
- Avg. volume (final 3 mo.)
- 1,220,900
- All-time high
- $76250.01 · Jun 2017
- All-time low
- $0.10 · Nov 2024
- Return since IPO
- -53.0%
- Beta
- 0.28
- Book value / share
- −$4.12
- Price / book
- -0.56
About Qualigen Therapeutics Inc
Qualigen Therapeutics, Inc. was a clinical-stage company developing treatments for cancer in adults and children. Its lead program, QN-302, was an investigational small molecule that selectively blocks transcription at G-quadruplexes (G4), in a Phase I trial for pancreatic cancer and other solid tumors. A Pan-RAS program for advanced solid tumors was in preclinical work.
Founded in 1996 and based in Carlsbad, California, the company was delisted from the Nasdaq in January 2026, last trading on January 20, 2026 at $2.33.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Carlsbad, CA
- Employees
- —
- IPO date
- June 24, 2015
- Delisted
- January 20, 2026
- SEC CIK
- 1460702
Qualigen Therapeutics financials before the delisting
The last 5 fiscal years Qualigen Therapeutics reported as a public company, fiscal year ending December.
QLGN revenue and net income
QLGN earnings per share
QLGN annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | −$6.2M | −$6.54 |
| FY2023 | $5.20M | −$13.4M | −$9.47 |
| FY2022 | $4.98M | −$21.0M | −$4.10 |
| FY2021 | $5.65M | −$17.9M | −$6.10 |
| FY2020 | $4.31M | −$20.4M | $1.07 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Qualigen Therapeutics stock FAQ
What happened to Qualigen Therapeutics stock?
Qualigen Therapeutics was delisted from the Nasdaq in January 2026. The final close was $2.33 on January 20, 2026.
Can I still buy QLGN stock?
No. QLGN is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on January 20, 2026.
What was the last price of QLGN?
QLGN last closed at $2.33 on January 20, 2026, which valued the company at about $4.74M.
How did Qualigen Therapeutics do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Qualigen Therapeutics reported revenue of $0.00 and net income of −$6.2M.
When did Qualigen Therapeutics go public?
Qualigen Therapeutics shares started trading on June 24, 2015.
QLGN no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.